It’s tough, as baseball great Yogi Berra once famously observed, to make predictions, especially about the future. But that’s the risky business we’ve signed up for tomorrow night, as I plan to ask a handful of visionaries to think big about how they see the San Francisco Bay Area biotech hub evolving over the next 20 years.
We at Xconomy have a terrific lineup of guests on our feature panel at Bay Area Life Sciences 2031, and I plan to press them to open up about what they really think. This gathering, which is close to a sell-out as of this writing, will be held from 5 pm to 8:30 pm tomorrow at UCSF’s Mission Bay campus, Genentech Hall. Registration starts at 5 pm, and the program gets going at 6 pm.
Reg Kelly, the director of QB3 will make some opening remarks, along with some comments from my colleague, the editor of Xconomy San Francisco, Wade Roush. Then I’ll start the conversation with a panel of invited leaders from academia, public and private biotech companies, and venture capital. Here’s the lineup:
—Jeff Bluestone, executive vice chancellor of UCSF.
—Peter Hirth, CEO of Berkeley, CA-based Plexxikon.
—Randy Scott, executive chairman of Redwood City, CA-based Genomic Health (NASDAQ: GHDX).
—Corey Goodman, managing director of venBio.
I’ll have questions of my own, but I’ll be sure to leave time for you to get your questions too. After that, we’ll have brief 3-4 minute overviews from four entrepreneurs who are betting their innovations of today will still matter in 2031. They are:
—Bill Newell, CEO of South San Francisco-based Sutro Biopharma.
—Nancy Stagliano, CEO of South San Francisco-based CytomX Therapeutics.
—Mickey Urdea, CEO of Emeryville, CA-based Tethys Bioscience.
—Dave Martin, CEO of South San Francisco-based AvidBiotics.
Once the panels and talks are done, it will be time for some top-notch networking that is a highlight of all the Xconomy events we’ve done around the country. If you haven’t gotten a ticket yet, you can get one here at the registration page. See you there at UCSF tomorrow night.
By posting a comment, you agree to our terms and conditions.